An international group of scientists and medical specialists, including HSE researchers, examined the role played by microRNA (miRNA) and long non-coding RNAs on the progression of ovarian cancer. Having analysed more than a hundred tumour samples, they found that miRNA can prevent cell mutation while long non-coding RNAs have the opposite effect of enabling such mutations. These findings can help design new drugs which act by regulating miRNA concentrations. The study was published in the International Journal of Molecular Sciences.
International conference 'Law in the Digital Age'
Registration is open until 18-00 (Moscow time) on February 22
Open House of the Master of International Business programme
Scientific Student Conference 'The Youth in Science: Challenges and Prospects'
January 29, 2024 - Deadline for Registration
International conference 'Birational Geometry'